Ultra-hypofractionated for Whole Breast Irradiation (WBI) Compared to Partial Breast Irradiation (PBI)

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age50+
SponsorOncology Institute of Vojvodina

About this trial

Female patients undergoing surgical treatment for early breast cancer and meeting the inclusion criteria for adjuvant breast radiotherapy were randomized into two groups. One group will receive adjuvant whole-breast radiotherapy in ultra-hypofractionated regimen of 26 Gy in 5 fractions. In contrast, the other group will receive partial breast irradiation with a dose of 26Gy in 5 fractions.

The study's objective is to compare the effects of both breast radiotherapy protocols in terms of locoregional disease control and survival and to compare the adverse effects of radiotherapy between the two protocols. To determine if there is a correlation between different parameters and the efficacy and degree of toxicity for both protocols.

Eligibility criteria

Qualifiers

Breast-conserving surgery

Invasive ductal carcinoma

Age ≥ 50

Tumor size ≤ 3 cm

Disqualifiers

Neoadjuvant systemic therapy

TNBC (triple-negative breast cancer)

Extensive intraductal component (EIC)

Lymphovascular invasion (LVI)

Trial design

Treatments tested in this trial

  • Ultra-fractionated WBI
  • Ultra-fractionated PBI

Treatment groups

100 Participants
are divided into 2 treatment groups